Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
Saved in:
| Title: | Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. |
|---|---|
| Authors: | Stamatouli AM; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT., Quandt Z; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Perdigoto AL; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT., Clark PL; Department of Immunobiology, Yale University, New Haven, CT., Kluger H; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Weiss SA; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Gettinger S; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Sznol M; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Young A; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Rushakoff R; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Lee J; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA., Bluestone JA; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Anderson M; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Herold KC; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT kevan.herold@yale.edu.; Department of Immunobiology, Yale University, New Haven, CT. |
| Source: | Diabetes [Diabetes] 2018 Aug; Vol. 67 (8), pp. 1471-1480. Date of Electronic Publication: 2018 Jun 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29937434 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stamatouli+AM%22">Stamatouli AM</searchLink>; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Quandt+Z%22">Quandt Z</searchLink>; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Perdigoto+AL%22">Perdigoto AL</searchLink>; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Clark+PL%22">Clark PL</searchLink>; Department of Immunobiology, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Kluger+H%22">Kluger H</searchLink>; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Weiss+SA%22">Weiss SA</searchLink>; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Gettinger+S%22">Gettinger S</searchLink>; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Sznol+M%22">Sznol M</searchLink>; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Young+A%22">Young A</searchLink>; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Rushakoff+R%22">Rushakoff R</searchLink>; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Bluestone+JA%22">Bluestone JA</searchLink>; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Anderson+M%22">Anderson M</searchLink>; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Herold+KC%22">Herold KC</searchLink>; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT kevan.herold@yale.edu.; Department of Immunobiology, Yale University, New Haven, CT. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2018 Aug; Vol. 67 (8), pp. 1471-1480. <i>Date of Electronic Publication: </i>2018 Jun 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29937434 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/dbi18-0002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1471 Titles: – TitleFull: Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stamatouli AM – PersonEntity: Name: NameFull: Quandt Z – PersonEntity: Name: NameFull: Perdigoto AL – PersonEntity: Name: NameFull: Clark PL – PersonEntity: Name: NameFull: Kluger H – PersonEntity: Name: NameFull: Weiss SA – PersonEntity: Name: NameFull: Gettinger S – PersonEntity: Name: NameFull: Sznol M – PersonEntity: Name: NameFull: Young A – PersonEntity: Name: NameFull: Rushakoff R – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Bluestone JA – PersonEntity: Name: NameFull: Anderson M – PersonEntity: Name: NameFull: Herold KC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2018 Aug Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1939-327X Numbering: – Type: volume Value: 67 – Type: issue Value: 8 Titles: – TitleFull: Diabetes Type: main |
| ResultId | 1 |